$688 Million is the total value of SECTOR GAMMA AS's 26 reported holdings in Q2 2017. The portfolio turnover from Q1 2017 to Q2 2017 was 15.4% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ABT | Buy | ABBOTT LABS | $74,730,000 | +27.6% | 1,537,342 | +16.6% | 10.86% | +16.7% |
BAX | Buy | BAXTER INTL INC | $64,798,000 | +20.6% | 1,070,333 | +3.3% | 9.42% | +10.2% |
BMY | Buy | BRISTOL MYERS SQUIBB CO | $49,557,000 | +16.5% | 889,390 | +13.7% | 7.20% | +6.5% |
PKI | Buy | PERKINELMER INC | $43,017,000 | +18.8% | 631,308 | +1.3% | 6.25% | +8.7% |
BSX | Buy | BOSTON SCIENTIFIC CORP | $39,847,000 | +12.5% | 1,437,480 | +1.0% | 5.79% | +2.9% |
LLY | Sell | LILLY ELI & CO | $39,113,000 | -29.7% | 475,250 | -28.1% | 5.69% | -35.7% |
GILD | Buy | GILEAD SCIENCES INC | $38,815,000 | +27.4% | 548,390 | +22.3% | 5.64% | +16.5% |
IRWD | Sell | IRONWOOD PHARMACEUTICALS INC | $34,609,000 | +4.5% | 1,833,097 | -5.5% | 5.03% | -4.4% |
SHPG | Buy | SHIRE PLCsponsored adr | $34,353,000 | +9.1% | 207,861 | +15.0% | 4.99% | -0.3% |
ANTM | Sell | ANTHEM INC | $33,752,000 | -0.3% | 179,410 | -12.3% | 4.91% | -8.8% |
IART | Buy | INTEGRA LIFESCIENCES HLDGS C | $26,886,000 | +30.7% | 493,230 | +1.0% | 3.91% | +19.5% |
BIO | Buy | BIO RAD LABS INCcl a | $26,013,000 | +14.4% | 114,942 | +0.8% | 3.78% | +4.6% |
PRGO | Buy | PERRIGO CO PLC | $22,138,000 | +34.8% | 293,140 | +18.5% | 3.22% | +23.2% |
MCK | Buy | MCKESSON CORP | $19,103,000 | +11.8% | 116,100 | +0.8% | 2.78% | +2.2% |
MASI | Sell | MASIMO CORP | $18,365,000 | -23.7% | 201,418 | -22.0% | 2.67% | -30.3% |
PDCO | PATTERSON COMPANIES INC | $18,134,000 | +3.8% | 386,232 | 0.0% | 2.64% | -5.1% | |
BIIB | New | BIOGEN IDEC INC | $15,685,000 | – | 57,800 | +100.0% | 2.28% | – |
CI | CIGNA CORPORATION | $14,106,000 | +14.3% | 84,270 | 0.0% | 2.05% | +4.5% | |
LH | Buy | LABORATORY CORP AMER HLDGS | $13,102,000 | +8.8% | 85,000 | +1.3% | 1.90% | -0.5% |
THC | Buy | TENET HEALTHCARE CORP | $11,124,000 | +149.2% | 575,180 | +128.2% | 1.62% | +127.7% |
LXRX | Buy | LEXICON PHARMACEUTICALS INC | $10,243,000 | +115.0% | 622,655 | +87.4% | 1.49% | +96.4% |
MNTA | Sell | MOMENTA PHARMACEUTICALS INC | $10,234,000 | +1.3% | 605,545 | -20.0% | 1.49% | -7.4% |
LPNT | Sell | LIFEPOINT HEALTH INC | $10,053,000 | -6.8% | 149,714 | -9.1% | 1.46% | -14.8% |
IPXL | Buy | IMPAX LABORATORIES INC | $9,488,000 | +40.4% | 589,311 | +10.3% | 1.38% | +28.3% |
OMI | Buy | OWENS & MINOR INC NEW | $5,661,000 | +12.2% | 175,874 | +20.6% | 0.82% | +2.5% |
ALXN | New | ALEXION PHARMACEUTICALS INC | $4,903,000 | – | 40,300 | +100.0% | 0.71% | – |
UTHR | Exit | UNITED THERAPEUTICS CORP DEL | $0 | – | -28,974 | -100.0% | -0.62% | – |
VRTX | Exit | VERTEX PHARMACEUTICALS INC | $0 | – | -267,050 | -100.0% | -4.64% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-08-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
BOSTON SCIENTIFIC CORP | 40 | Q1 2023 | 9.9% |
BIO RAD LABS INC | 40 | Q1 2023 | 4.7% |
BRISTOL-MYERS SQUIBB CO | 38 | Q3 2023 | 11.9% |
BAXTER INTL INC | 34 | Q3 2023 | 12.7% |
CARDINAL HEALTH INC | 34 | Q3 2023 | 8.1% |
PERKINELMER INC | 33 | Q2 2021 | 6.3% |
BIOGEN INC | 30 | Q3 2023 | 7.6% |
ELEVANCE HEALTH INC | 30 | Q3 2023 | 5.6% |
GILEAD SCIENCES INC | 29 | Q3 2023 | 14.0% |
TENET HEALTHCARE CORP | 28 | Q3 2023 | 4.3% |
View SECTOR GAMMA AS's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-05 |
13F-HR | 2023-11-06 |
13F-HR | 2023-08-09 |
13F-HR | 2023-05-12 |
13F-HR/A | 2023-02-08 |
13F-HR | 2023-02-07 |
13F-HR | 2022-11-09 |
13F-HR | 2022-08-05 |
13F-HR | 2022-05-06 |
13F-HR | 2022-02-08 |
View SECTOR GAMMA AS's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.